MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a mitochondria-derived peptide that has generated significant interest in endurance sports science. Unlike most peptides, MOTS-c is encoded within the mitochondrial genome itself — making it a direct messenger between mitochondria and the cell nucleus.
AMPK Activation and Metabolic Flexibility
MOTS-c's primary mechanism of action is the activation of AMPK (AMP-activated protein kinase), often called the "metabolic master switch." AMPK activation triggers a cascade of metabolic adaptations that are highly beneficial for endurance athletes: increased fatty acid oxidation (fat burning for fuel), enhanced glucose uptake in muscle cells, improved mitochondrial biogenesis, and increased insulin sensitivity.
Exercise Performance Data
Animal studies have shown that MOTS-c administration significantly improves exercise capacity, with treated mice running substantially farther and longer than controls on treadmill tests. The mechanism appears to involve enhanced metabolic flexibility — the ability to seamlessly switch between carbohydrate and fat oxidation based on exercise intensity and fuel availability.
Recovery and Anti-Fatigue Effects
Beyond performance, MOTS-c demonstrates significant anti-fatigue properties by reducing the accumulation of metabolic byproducts during intense exercise and accelerating their clearance during recovery. This translates to reduced delayed-onset muscle soreness (DOMS) and faster readiness for subsequent training sessions.